3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 4
2
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Small Cell Lung Carcinoma
2
NSCLC
2
Thyroid Neoplasms
1
Sarcoma
1
Proteinuria
1
Platinum-resistant Ovarian Cancer (PROC)
1
Advanced Thyroid Cancer Patients Who Received Target Therapy
1
Interventions
icotinib
2
anlotinib
2
Drug Therapy
2
lorlatinib
1
Thalidomide
1
Docetaxel
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
NSCLC
×
anlotinib
×
Clear all
NCT05387109
2022-05-24
pcwaintrl
Tang-Du Hospital
Phase 4
Unknown
41 enrolled
NCT03799601
2019-01-10
ALTER-L013
Tongji Hospital
Phase 4
Unknown
45 enrolled